Technetium-99 Conjugated with Methylene Diphosphonate Ameliorates Glucocorticoid Induced Osteoporosis by Inhibiting Osteoclastogenesis

about

Technetium-99 Conjugated with Methylene Diphosphonate Ameliorates Glucocorticoid Induced Osteoporosis by Inhibiting Osteoclastogenesis

Item

http://www.wikidata.org/entity/Q58567104

description

scientific article published on 14 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Technetium-99 Conjugated with ...... Inhibiting Osteoclastogenesis

@en

Technetium-99 Conjugated with ...... Inhibiting Osteoclastogenesis

@nl

type

Item

label

Technetium-99 Conjugated with ...... Inhibiting Osteoclastogenesis

@en

Technetium-99 Conjugated with ...... Inhibiting Osteoclastogenesis

@nl

prefLabel

Technetium-99 Conjugated with ...... Inhibiting Osteoclastogenesis

@en

Technetium-99 Conjugated with ...... Inhibiting Osteoclastogenesis

@nl

P1476

Technetium-99 Conjugated with ...... Inhibiting Osteoclastogenesis

@en

P2093

Jianhong Li

http://www.w3.org/2001/XMLSchema#string

Liling Xu

http://www.w3.org/2001/XMLSchema#string

Ying Ning

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.

(99)Tc-MDP treatment for the therapy of rheumatoid arthritis, choroidal neovascularisation and Graves' ophthalmopathy.

Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis.

Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Technetium-99 conjugated with methylene diphosphonate ameliorates ovariectomy-induced osteoporotic phenotype without causing osteonecrosis in the jaw.

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.

Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis.

Disease control with glucocorticoid therapy in rheumatoid arthritis.

Management of glucocorticoid-induced osteoporosis.

P304

7902760

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/7902760

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Lianjie Shi

Xuewu Zhang

P577

2018-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30406140

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

6204167

http://www.w3.org/2001/XMLSchema#string